NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

酒糟治療的全球市場:2018年∼2022年

Global Rosacea Treatment Market 2018-2022

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 701091
出版日期 內容資訊 英文 107 Pages
訂單完成後即時交付
價格
酒糟治療的全球市場:2018年∼2022年 Global Rosacea Treatment Market 2018-2022
出版日期: 2018年09月07日內容資訊: 英文 107 Pages
簡介

關於酒糟

酒糟,是一般影響白人人口的慢性皮膚疾病。酒糟的正確原因依然不明,對於這個疾病沒有特別的治療方法。研究引進控制症狀至最小限度的治療方法。

Technavio的分析師預測,從2018年到2022年之間,全球酒糟治療市場將以2.46%的年複合成長率成長。

本報告提供全球酒糟治療市場相關調查分析,市場規模與成長率,市場趨勢,市場的推動要素與課題,市場機會驗證,主要供應商等相關的系統性資訊。

目錄

第1章 摘要整理

第2章 調查範圍

第3章 調查方法

第4章 市場情形

  • 市場生態系統
  • 市場特性
  • 市場區隔分析

第5章 市場規模

  • 市場定義
  • 市場規模(2017年)
  • 市場規模及預測(2017-2022年)

第6章 波特的五力分析

  • 買主談判力
  • 供應商談判力
  • 新加入廠商的威脅
  • 替代品的威脅
  • 競爭對手的威脅
  • 市場情形

第7章 開發平台的風景

  • 開發中的藥物

第8章 市場區隔:各應用領域

  • 市場區隔:各應用領域(2017-2022年)
  • 比較:各應用領域
  • 局部
  • 口服
  • 市場機會:各應用領域

第9章 客戶形勢

第10章 地區形勢

  • 各地區市場區隔(2017-2022年)
  • 地區比較
  • 南北美洲
  • 歐洲、中東、非洲地區
  • 亞太地區
  • 主要國家
  • 市場機會

第11章 決策架構

第12章 成長要素與課題

  • 市場成長要素
  • 市場課題

第13章 市場趨勢

  • 局部治療的使用
  • 轉移組合產品
  • 技術的進步

第14章 業者情勢

  • 概要
  • 創造性破壞狀況

第15章 供應商分析

  • 交易廠商
  • 供應商分類
  • 供應商的市場定位
  • ALLERGAN
  • Bayer
  • Bausch Health
  • Nestle
  • Sol-Gel Technologies

第16章 附錄

  • 簡稱的清單
目錄
Product Code: IRTNTR23696

About Rosacea

Rosacea is a chronic skin disease that generally affects the white population. The exact cause of rosacea remains unknown. As a result, there is no specific cure for the disease. Research is leading to the introduction of methods to treat the condition by minimizing its symptoms.

Technavio's analysts forecast the Global Rosacea Treatment Market to grow at a CAGR of 2.46% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the rosacea treatment market. To calculate the market size, the report considers the revenue generated by sales of topical and oral rosacea treatment products across the globe.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Rosacea Treatment Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • ALLERGAN
  • Bayer
  • Bausch Health
  • Nestle
  • Sol-Gel Technologies

Market driver

  • Growing rate of incidence of rosacea
  • For a full, detailed list, view our report

Market challenge

  • High competition from generic drugs
  • For a full, detailed list, view our report

Market trend

  • Use of topical treatment
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: PIPELINE LANDSCAPE

  • Drugs under development

PART 08: MARKET SEGMENTATION BY APPLICATION

  • Segmentation by application
  • Comparison by application
  • Topical - Market size and forecast 2017-2022
  • Oral - Market size and forecast 2017-2022
  • Market opportunity by application

PART 09: CUSTOMER LANDSCAPE

PART 10: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Key leading countries
  • Market opportunity

PART 11: DECISION FRAMEWORK

PART 12: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 13: MARKET TRENDS

  • Use of topical treatment
  • Shift toward combination products
  • Technological advances

PART 14: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 15: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • ALLERGAN
  • Bayer
  • Bausch Health
  • Nestle
  • Sol-Gel Technologies

PART 16: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Parent market
  • Exhibit 02: Global dermatology market
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Rosacea pipeline landscape
  • Exhibit 19: Molecules in pipeline
  • Exhibit 20: Application - Market share 2017-2022 (%)
  • Exhibit 21: Comparison by application
  • Exhibit 22: Topical - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: Topical - Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Oral - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 25: Oral - Year-over-year growth 2018-2022 (%)
  • Exhibit 26: Market opportunity by application
  • Exhibit 27: Customer landscape
  • Exhibit 28: Global - Market share by geography 2017-2022 (%)
  • Exhibit 29: Regional comparison
  • Exhibit 30: Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 31: Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 32: EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 33: EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 34: APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 35: APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 36: Key leading countries
  • Exhibit 37: Market opportunity
  • Exhibit 38: Vendor landscape
  • Exhibit 39: Landscape disruption
  • Exhibit 40: Vendors covered
  • Exhibit 41: Vendor classification
  • Exhibit 42: Market positioning of vendors
  • Exhibit 43: ALLERGAN - Overview
  • Exhibit 44: ALLERGAN - Business segments
  • Exhibit 45: ALLERGAN - Organizational developments
  • Exhibit 46: ALLERGAN - Geographic focus
  • Exhibit 47: ALLERGAN - Segment focus
  • Exhibit 48: ALLERGAN - Key offerings
  • Exhibit 49: ALLERGAN - Key customers
  • Exhibit 50: Bayer - Overview
  • Exhibit 51: Bayer - Business segments
  • Exhibit 52: Bayer - Organizational development
  • Exhibit 53: Bayer - Geographic focus
  • Exhibit 54: Bayer - Segment focus
  • Exhibit 55: Bayer - Key offerings
  • Exhibit 56: Bayer - Key customers
  • Exhibit 57: Bausch Health - Overview
  • Exhibit 58: Bausch Health - Business segments
  • Exhibit 59: Bausch Health - Organizational developments
  • Exhibit 60: Bausch Health - Geographic focus
  • Exhibit 61: Bausch Health - Segment focus
  • Exhibit 62: Bausch Health - Key offerings
  • Exhibit 63: Bausch Health - Key customers
  • Exhibit 64: Nestle - Overview
  • Exhibit 65: Nestle - Business segments
  • Exhibit 66: Nestle - Organizational developments
  • Exhibit 67: Nestle - Geographic focus
  • Exhibit 68: Nestle - Segment focus
  • Exhibit 69: Nestle - Key offerings
  • Exhibit 70: Nestle - Key customers
  • Exhibit 71: Sol-Gel Technologies - Overview
  • Exhibit 72: Sol-Gel Technologies - Business segments
  • Exhibit 73: Sol-Gel Technologies - Organizational developments
  • Exhibit 74: Sol-Gel Technologies - Segment focus
  • Exhibit 75: Sol-Gel Technologies - Key offerings
  • Exhibit 76: Sol-Gel Technologies - Key customers